Stocks and InvestingStocks and Investing
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022

Yigal Nochomovitz Maintained (ARCT) at Strong Buy with Decreased Target to $86 on, Mar 15th, 2022


Published on 2024-10-27 20:05:15 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Buy with Decreased Target from $114 to $86 on, Mar 15th, 2022.

Yigal has made no other calls on ARCT in the last 4 months.



There are 2 other peers that have a rating on ARCT. Out of the 2 peers that are also analyzing ARCT, 1 agrees with Yigal's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Steven Seedhouse of "Raymond James" Upgraded from Sell to Hold on, Monday, January 31st, 2022


This is the rating of the analyst that currently disagrees with Yigal


  • John Abbott of "Wells Fargo" Maintained at Buy with Decreased Target to $107 on, Tuesday, March 1st, 2022